Kuros Biosciences gained FDA approval for its IND application to initiate a Phase IIA clinical trial evaluating Fibrin-PTH orthobiologic in single-level TLIF to treat degenerative disc disease, with autograft as comparator.
Wellmark Blue Cross Blue Shield established positive coverage for minimally invasive surgical sacroiliac joint fusion using SI-BONE's iFuse Implant System in South Dakota and Iowa.
ApiFix received Humanitarian Device Exemption approval to market the MID-C Minimally Invasive Deformity Correction system to treat adolescent idiopathic scoliosis.
Ortho Regenerative Technologies entered into an agreement to evaluate a commercial product from an unnamed orthopedic company partner for use with Ortho's Ortho-R biopolymer matrix.Â